Submaximal cycle ergometer test-retest
ProcedurePerforming a submaximal cycle ergometer test twice
NCT Number: NCT07383740
The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA).
Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks.
The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA.
To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.
Trial opening soon.
Get Notified30 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Performing a submaximal cycle ergometer test twice
Time frame: Time between first and second submaximal cycle ergometer test should be one week.
An estimated VO2-max value is obtained by performing the Ekblom Bak submaximal cycle ergometer test.
Contact information is provided by the study sponsor or research team.
Daniel Karsberg Zotterman, MSc
CONTACT
Stefan Lundqvist, PhD
CONTACT
Vastra Gotaland Region
Other Gov
Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip- and/or Knee Osteoarthritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07532070
Agnosia, Arthritis
San Antonio, Nevada, United States
View Trial DetailsNCT07423858
Arthritis, Joint Diseases
Utrecht, Netherlands
View Trial DetailsNCT07202286
Acceptability, Accuracy
Nijmegen, Netherlands
View Trial DetailsNCT07334132
Inflammatory Joint Disease (IJD), Nausea
View Trial Details